FIELD: pharmaceuticals.
SUBSTANCE: group of inventions relates to the use of a sterile aqueous ophthalmic solution for treating corneal wounds and a method of treating a corneal wound. Used solution contains N-(N-acetylcysteinyl)chitosan, having content of free thiol groups equal to 80 mcmole/g of polymer to 280 mcmole/g of polymer, or a pharmaceutically acceptable salt thereof in a defined concentration and a carrier. Method of treating a corneal wound involves depositing a sterile aqueous ophthalmic solution, including N-(N-acetylcysteinyl)chitosan, on said wound.
EFFECT: group of inventions provides a storage stable ophthalmic solution with improved efficacy in treating corneal wounds.
16 cl, 2 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS OPHTHALMIC SOLUTION AND METHOD OF TREATING DRY EYE SYNDROME | 2015 |
|
RU2688935C2 |
| HYDROGEN SULPHIDE RELEASING POLYMER COMPOUNDS | 2017 |
|
RU2768716C2 |
| APPLICATION OF POLYMERS | 2007 |
|
RU2432181C2 |
| OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
| OPHTHALMOLOGIC GEL AND METHOD OF ITS PREPARATION | 2007 |
|
RU2340327C1 |
| PROSTHESIS FOR CARRYING OUT SUBEPITHELIAL IMPLANTATION OPERATIONS | 1989 |
|
RU2114579C1 |
| COMPOSITIONS AND METHODS FOR EYE TREATMENT | 2019 |
|
RU2793736C2 |
| SORBENT CONTAINING MICROPOROUS MATERIAL, AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2700051C2 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2019 |
|
RU2792627C2 |
| COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS | 2020 |
|
RU2795913C2 |
